Controversial FDA Approval: The BMJ investigation reveals doubts about efficacy and high cost of antibiotic Recarbrio, questioning FDA’s standards.
Latest in clinical trials
-
-
CancerRIKENSciTech News
Breakthrough Cancer Treatment: Japan’s Alpha Particle Assassin
by Amir Husseinby Amir HusseinJapanese scientists develop a groundbreaking cancer treatment using alpha radiation, selectively killing cancer cells while sparing healthy tissue.
-
CancerDrugsHeartInflammationNew York UniversitySciTech News
Experimental Cancer Drug Shows Potential in Slowing Inflammation Associated with Heart Disease
Experimental cancer drug saracatinib shows potential in slowing inflammation linked to heart disease, according to a study by NYU Grossman …
-
Cell MembranesDietMedicineNutritionSciTech News
New Discovery: Fatty Fish Offers Additional Health Benefits
New study finds that consuming fatty fish lowers lipophilic index, improves cell membrane fluidity, and reduces cardiovascular risk.
-
BioinformaticsBiologyDNAGeneticsGenomicsMount Sinai HospitalMount Sinai School Of MedicineSciTech News
Genetic Jigsaw: Piecing Together the Human Pangenome
by Manuel Costaby Manuel CostaDiscover how Dr. Eimear Kenny and the international Human Pangenome Reference Consortium are advancing genomics with a more inclusive human …
-
CancerDrugsLeukemiaMitochondriaNew York UniversitySciTech News
Death to Blood Cancer Cells: New Drug Combination Could Revive the Power of Leading Treatment
Researchers have made a significant breakthrough in the treatment of acute myeloid leukemia (AML) by uncovering the mechanism behind resistance…
- 1
- 2